跳至主要内容
临床试验/NCT03243942
NCT03243942已完成2 期

Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement

Thomas Jefferson University1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2017年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
56
试验地点
1
主要终点
Agreement between SHAPE and pressure catheter measurements

研究概览

简要总结

The fundamental hypothesis of this project is that real-time intracardiac pressures can be monitored and quantified noninvasively in humans using a novel contrast-enhanced ultrasound technique called subharmonic-aided pressure estimation (SHAPE).This study will use contrast echocardiography to assess the accuracy of SHAPE compared to simultaneously acquired intracardiac pressures measured invasively during cardiac catheterization. This study is designed to verify that contrast echocardiography using the SHAPE method, already proven in a canine model and tested in a human pilot study can be used as a surrogate for cardiac catheterization with sufficient accuracy to allow clinical applicability in humans.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Be scheduled for a cardiac catheterization procedure
  • Adult patients over the age of 21
  • Acceptable baseline echocardiographic images in the supine position
  • If a female of child-bearing potential, must have a negative pregnancy test
  • Provide written informed consent

排除标准

  • Clinically unstable patients, e.g., those who are clinically in decompensated heart failure or having active chest pain or presenting for admission with an unstable anginal syndrome
  • Patients in whom introduction of a catheter into the left ventricle is contraindicated or would potentially be dangerous, e.g., patients with active ventricular arrhythmias or with significant aortic valve stenosis where crossing the aortic valve may be difficult and not clinically necessary
  • Patients with anatomic right-to-left, bi-directional, or transient right-to-left cardiac shunts where Definity could traverse as a bolus
  • Patients with known hypersensitivity to Definity
  • Females who are pregnant or nursing

研究组 & 干预措施

Definity for pressure measurements

Experimental

2 vials of activated Definity mixed with 50 ml saline. As per manufacturer's recommendation the infusion rate may vary between 4-10 ml/min (to provide diagnostic intracardiac contrast visibility).

干预措施: Definity (Drug)

结局指标

主要结局

Agreement between SHAPE and pressure catheter measurements

时间窗: up to 1 day

Correlation

Error between SHAPE and pressure catheter measurements

时间窗: up to 1 day

ANOVA/Post-hoc comparisons

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jaydev Dave

Assistant Professor

Thomas Jefferson University

研究点 (1)

Loading locations...

相似试验